Allurar Intravitreal

Alurar da ke cikin intravitreal shine harbin magani a cikin ido. Cikin ido yana cike da ruwa mai kama da jelly (vitreous). A yayin wannan aikin, mai kula da lafiyar ku ya yi allurar magani a cikin kwayar cutar, kusa da kwayar ido a bayan idon. Magungunan na iya magance wasu matsalolin ido kuma zai iya taimakawa hangen nesa. Ana amfani da wannan hanyar mafi yawa don samun matakin magani mafi girma a tantanin ido.

Ana yin aikin a ofishin mai ba da sabis. Yana daukan kimanin minti 15 zuwa 30.

• Za a sanya digo a idanunku don fadada (fadada) daliban.
• Za ku kwance fuska sama a cikin yanayi mai kyau.
• Idanunku da fatar ido za a tsabtace.
• Za a sanya digo na ƙwanƙwasa a cikin idonka.
• Devicearamin na’ura za ta buɗe idanun idanunka a buɗe yayin aikin.
• Za a umarce ku da ku kalli ɗayan idon.
• Za a yi amfani da ƙaramin allura a cikin idonka. Kuna iya jin matsi, amma ba zafi ba.
• Za'a iya sanya digo na rigakafi a cikin idonka.

Kuna iya samun wannan hanyar idan kuna da:

• Rushewar Macular: Rashin lafiyar ido wanda a hankali ke lalata kaifi, hangen nesa na tsakiya
• Macular edema: Kumburi ko kaurin macula, ɓangaren idonka wanda ke bayar da kaifi, hangen nesa
• Ciwon kwayar ido wanda yake haifar da cututtukan sikari wanda zai iya haifar da sabbin hanyoyin jini, wadanda ba su dace ba, su yi girma a cikin kwayar ido, bangaren bayan idonka.
• Uveitis: Kumburi da kumburi tsakanin kwayar ido
• Rufewar ido ta ido: toshewar jijiyoyin da ke dauke da jini daga kwayar ido da ido
• Endophthalmitis: Kamuwa da cuta a cikin cikin ido

Wani lokaci, ana ba da allurar rigakafi ta intravitreal a matsayin wani ɓangare na aikin tiyatar ido na yau da kullun. Wannan yana guje wa yin amfani da digo bayan tiyata.

Abubuwan da ke faruwa ba su da yawa, kuma ana iya sarrafa su da yawa. Suna iya haɗawa da:

• Pressureara matsi a cikin ido
• Masu shawagi
• Kumburi
• Zuban jini
• Farkon goge baki
• Lalacewa ga tantanin ido ko jijiyoyi ko sifofin kewaye
• Kamuwa da cuta
• Rashin hangen nesa
• Rashin ido (ba safai ba)
• Sakamakon sakamako daga magungunan da ake amfani dasu

Tattauna haɗarin takamaiman magungunan da aka yi amfani da su a cikin idonka tare da mai samar maka.

Faɗa wa mai ba ka sabis game da:

• Duk wata matsalar lafiya
• Magungunan da kuka sha, gami da duk wani magungunan kanti
• Duk wani rashin lafiyan
• Duk wani yanayin zubar jini

Bin hanyar:

• Kuna iya jin sensan abubuwan jin daɗi a cikin ido kamar matsi da grittiness, amma kada a sami ciwo.
• Za a iya samun ɗan zubar jini a kan farin ido.Wannan al'ada ne kuma zai tafi.
• Kuna iya ganin masu yawo a idanunku. Za su inganta a tsawon lokaci.
• KADA KA shafa idanunka har tsawon kwanaki.
• Guji yin iyo na aƙalla kwanaki 3.
• Yi amfani da maganin digon ido kamar yadda aka umurta.

Yi rahoton duk wani ciwo na ido ko rashin jin daɗi, ja, ƙwarewa zuwa haske, ko canje-canje a cikin hangen nesa ga mai ba da sabis kai tsaye.

Shirya alƙawari mai zuwa tare da mai ba da sabis kamar yadda aka umurta.

Hannunku ya dogara da yawancin yanayin da ake bi da su. Ganin ka na iya zama mai karko ko inganta bayan aikin. Kila iya buƙatar allura fiye da ɗaya.

Kwayar rigakafi - allurar intravitreal; Triamcinolone - intravitreal allura; Dexamethasone - allurar intravitreal; Lucentis - allurar intravitreal; Avastin - allurar intravitreal; Bevacizumab - allurar intravitreal; Ranibizumab - allurar intravitreal; Magungunan anti-VEGF - allurar intravitreal; Macular edema - allurar intravitreal; Retinopathy - allurar intravitreal; Rufewar jijiyoyin ido - allurar intravitreal

Cibiyar Nazarin Ilimin Lafiya ta Amurka. Matsalar lalacewar macular PPP 2019. www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp. An sabunta Oktoba 2019. An shiga Janairu 13, 2020.

Kim JW, Mansfield NC, Murphree AL. Retinoblastoma. A cikin: Schachat AP, Sadda SVR, Hinton DR, Wilkinson CP, Wiedemann P, eds. Ryan's Retina. Na 6 ed. Philadelphia, PA: Elsevier; 2018: babi na 132.

Mitchell P, Wong TY; Workingungiyar Aiki na Maganin Ciwon Macular Edema. Abubuwan kulawa don cutar cutar macular edema. Am J Ophthalmol. 2014; 157 (3): 505-513. PMID: 24269850 www.ncbi.nlm.nih.gov/pubmed/24269850.

Rodger DC, Shildkrot YE, Elliott D. Mai cutar endophthalmitis. A cikin: Yanoff M, Duker JS, eds. Ilimin lafiyar ido. 5th ed. Philadelphia, PA: Elsevier; 2019: babi na 7.9.

Shultz RW, Maloney MH, Bakri SJ. Yin allurai a cikin Intravitreal da kuma sanya magunguna. A cikin: Yanoff M, Duker JS, eds. Ilimin lafiyar ido. 5th ed. Philadelphia, PA: Elsevier; 2019: babi na 6.13.